Blueprint Page
Explore the comprehensive blueprint for Physician Associates, covering all essential topics and resources.
Book Your Session
Enhance your skills with personalised tutoring sessions tailored for Physician Associates.
Image: "Herpes" by the Centers for Disease Control and Prevention (CDC) is in the public domain. Link to the source.
Herpes Labialis (Cold Sores)
Introduction | Aetiology and Risk Factors | Clinical Presentation | Diagnosis | Management and Treatment | Prevention | When to Refer | References
Introduction
Herpes labialis, commonly known as cold sores, is a recurrent viral infection caused by the herpes simplex virus (HSV), primarily HSV-1. It is characterised by painful vesicular lesions on the lips and perioral region. Cold sores are highly contagious and are typically self-limiting, but they can cause significant discomfort and social embarrassment.
Aetiology and Risk Factors
Herpes labialis is caused by the herpes simplex virus type 1 (HSV-1), though HSV-2 (commonly associated with genital herpes) can also cause cold sores, albeit less frequently:
- Initial Infection: Primary infection usually occurs in childhood and may be asymptomatic or present as gingivostomatitis. The virus then remains dormant in the trigeminal ganglion and can reactivate later in life.
- Reactivation Triggers: Several factors can trigger reactivation of the virus, leading to cold sores, including:
- Stress (physical or emotional)
- Sunlight or UV exposure
- Fever or illness (e.g., common cold, influenza)
- Menstruation
- Immunosuppression
- Trauma to the affected area
- Transmission: The virus is spread through direct contact with an active lesion or through saliva, making it highly contagious during outbreaks.
Clinical Presentation
Herpes labialis typically progresses through several stages:
- Prodromal Symptoms:
- Tingling, itching, or burning sensation around the lips or nose, usually 24-48 hours before the appearance of lesions.
- Vesicular Stage:
- Small, fluid-filled vesicles appear on a red, inflamed base, typically on the lip margin or perioral skin. These vesicles are often painful and can coalesce to form larger blisters.
- Ulcerative Stage:
- The vesicles rupture, leaving shallow ulcers that gradually crust over. The ulcers are highly infectious during this stage.
- Healing Stage:
- The crusts eventually fall off, and the skin heals without scarring in most cases. The entire cycle usually lasts about 7-10 days.
Diagnosis
The diagnosis of herpes labialis is primarily clinical, based on the characteristic appearance and history of recurrent lesions:
- History: A history of recurrent lesions in the same area, often triggered by stress, sun exposure, or other factors, supports the diagnosis.
- Physical Examination: The typical progression from tingling to vesicles and then crusting is highly indicative of herpes labialis.
- Laboratory Tests: Usually not necessary for a typical presentation, but in atypical cases or for confirmation, the following can be used:
- Viral Culture or PCR: Swabs from the vesicles can be tested for HSV DNA.
- Tzanck Smear: A less commonly used test that can show multinucleated giant cells typical of herpes infections.
Management and Treatment
Management of herpes labialis focuses on reducing symptoms, accelerating healing, and preventing recurrence:
1. Self-Care
- Avoid Triggers: Advise patients to avoid known triggers such as excessive sun exposure or stress. Use of lip balm with sunscreen can help prevent UV-induced reactivation.
- Hygiene Measures: Encourage patients to avoid touching the lesions, wash hands frequently, and avoid sharing personal items such as towels or lip balm to prevent spreading the virus.
2. Topical Treatments
- Topical Antivirals:
- Acyclovir Cream: Apply five times daily for 5 days. This can reduce the duration of symptoms if started early.
- Topical Anaesthetics:
- Lidocaine Gel: Can be applied to relieve pain and discomfort, particularly during the vesicular stage.
3. Oral Treatments
- Oral Antivirals: For more severe or frequent outbreaks, oral antivirals can be prescribed:
- Acyclovir: 200 mg five times daily for 5 days.
- Valaciclovir: 2 g twice daily for 1 day.
- Famciclovir: 1500 mg as a single dose.
- Prophylactic Therapy: In cases of frequent recurrences (e.g., more than six episodes per year), long-term suppressive therapy with oral antivirals may be considered.
Prevention
Preventing herpes labialis focuses on reducing the frequency of recurrences and limiting the spread of the virus:
- Avoid Known Triggers: As mentioned, sun protection, stress management, and avoiding trauma to the lips can help prevent outbreaks.
- Lifestyle Modifications: Maintaining a healthy lifestyle, including adequate sleep, nutrition, and stress reduction, may help reduce the frequency of outbreaks.
- Prophylactic Antivirals: For patients with frequent or severe outbreaks, daily antiviral therapy can be effective in reducing recurrences.
When to Refer
Referral to a specialist is generally not required for typical cases of herpes labialis, but may be necessary in the following situations:
- Severe or Atypical Presentation: If the lesions are unusually severe, extensive, or do not follow the typical clinical course, referral to a dermatologist may be warranted.
- Immunocompromised Patients: Patients with weakened immune systems (e.g., those with HIV, cancer, or on immunosuppressive therapy) may require specialist care, as they are at higher risk of severe or disseminated herpes infections.
- Complications: Referral may be necessary if complications such as secondary bacterial infection or significant ocular involvement occur.
References
- British Association of Dermatologists (2024) Guidelines for the Management of Herpes Labialis. Available at: https://www.bad.org.uk (Accessed: 26 August 2024).
- National Institute for Health and Care Excellence (2024) Herpes Simplex Virus: Diagnosis and Management. Available at: https://www.nice.org.uk/guidance/ng98 (Accessed: 26 August 2024).
- British National Formulary (2024) Antiviral Medications and Their Use in Herpes Simplex Virus Infections. Available at: https://bnf.nice.org.uk/ (Accessed: 26 August 2024).